https://de.marketscreener.com/kurs/aktie/HELIX-BIOPHARMA-CORP-1410302/news/Helix-BioPharma-Corp-wird-neue-praklinische-Daten-zu-L-DOS47-in-Kombination-mit-PD1-Checkpoint-Inh-45045384/?utm_source=telegram&utm_medium=social&utm_campaign=share